![Angelika Goncalves DaSilva](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Angelika Goncalves DaSilva
Plus aucun poste en cours
Profil
Angelika Goncalves DaSilva worked as a Manager of Operations & Investor Relations at Trillium Therapeutics ULC.
Anciens postes connus de Angelika Goncalves DaSilva
Sociétés | Poste | Fin |
---|---|---|
TRILLIUM THERAPEUTICS | Directeur des opérations | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Trillium Therapeutics ULC
![]() Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |